Drug:
Reaction: DERMATITIS ATOPIC
20260101 - 20261231
No. 1801 - 1900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1801 | 26744135 |
US |
18 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1802 | 26744142 |
US |
51 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1803 | 26744165 |
US |
6 | 1 |
Dermatitis atopic, Dry skin, Crying, Pruritus, Skin fissures, Sleep disorder, Rash, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 1804 | 26744173 |
US |
12 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1805 | 26744175 |
US |
36 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1806 | 26744570 |
US |
3 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1807 | 26744592 |
US |
62 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, CALCIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 1808 | 26744634 |
US |
34 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1809 | 26744639 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1810 | 26744879 |
US |
||
Alopecia, Dermatitis atopic, Folliculitis, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1811 | 26745050 |
US |
40 | 2 |
Dermatitis atopic, Eczema, |
||||
DUPILUMAB, CHORIOGONADOTROPIN ALFA, GANIRELIX ACETATE, LEUPROLIDE ACETATE, MENOTROPINS, |
||||
| 1812 | 26745061 |
US |
73 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1813 | 26745062 |
US |
34 | 2 |
Dermatitis atopic, Therapeutic response decreased, Injection site reaction, |
||||
DUPILUMAB, |
||||
| 1814 | 26745072 |
US |
72 | 2 |
Dermatitis atopic, Eye pruritus, |
||||
DUPILUMAB, |
||||
| 1815 | 26745429 |
US |
55 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1816 | 26745436 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1817 | 26746097 |
US |
22 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1818 | 26746126 |
US |
1 | |
Dermatitis atopic, Off label use, |
||||
DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUPROPION, BIMATOPROST, MAGNESIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, ROSUVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE, BRINZOLAMIDE/BRIMONIDINE TARTRATE, ERGOCALCIFEROL, |
||||
| 1819 | 26746317 |
US |
31 | 2 |
Dermatitis atopic, Rash erythematous, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1820 | 26746326 |
US |
24 | 1 |
Dermatitis atopic, Rash erythematous, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1821 | 26746343 |
US |
25 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1822 | 26746349 |
US |
21 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1823 | 26746355 |
US |
2 | |
Eye disorder, Vulvovaginal mycotic infection, Vulvovaginal pruritus, Vulvovaginal burning sensation, Dermatitis atopic, Pruritus, Insomnia, Feeling abnormal, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, FEXOFENADINE HYDROCHLORIDE, |
||||
| 1824 | 26746665 |
US |
19 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1825 | 26746669 |
US |
18 | 2 |
Fear of injection, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1826 | 26746884 |
US |
11 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1827 | 26736143 |
US |
30 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1828 | 26736158 |
US |
11 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1829 | 26736299 |
US |
12 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1830 | 26736304 |
US |
65 | 2 |
Neurodermatitis, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1831 | 26736308 |
US |
50 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1832 | 26736475 |
US |
69 | 1 |
Dermatitis atopic, Drug ineffective, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 1833 | 26737640 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1834 | 26737655 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1835 | 26737662 |
US |
2 | |
Dermatitis atopic, Rash, Blister, Skin ulcer, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1836 | 26737668 |
US |
4 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1837 | 26737670 |
US |
1 | |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1838 | 26737686 |
US |
9 | 1 |
Dermatitis atopic, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 1839 | 26737696 |
US |
15 | 2 |
Dermatitis atopic, Product dose omission issue, Off label use, |
||||
DUPILUMAB, |
||||
| 1840 | 26737708 |
US |
48 | 2 |
Dermatitis atopic, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, AMLODIPINE, BACLOFEN, DULOXETINE HYDROCHLORIDE, DULOXETINE, ESZOPICLONE, FLUCONAZOLE, FLUOCINOLONE ACETONIDE, |
||||
| 1841 | 26737710 |
US |
36 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1842 | 26737754 |
US |
1 | |
Injection site discomfort, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CICLESONIDE, IPRATROPIUM BROMIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 1843 | 26737765 |
US |
38 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1844 | 26737770 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1845 | 26737780 |
US |
56 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1846 | 26737788 |
US |
46 | 1 |
Erythema, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1847 | 26737807 |
US |
64 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1848 | 26737828 |
US |
53 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1849 | 26737833 |
US |
2 | |
Dermatitis atopic, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1850 | 26737835 |
US |
27 | 2 |
Dermatitis atopic, Eye irritation, |
||||
DUPILUMAB, |
||||
| 1851 | 26737854 |
US |
36 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1852 | 26737864 |
US |
64 | 2 |
Dermatitis atopic, Therapeutic response shortened, Injection site pain, |
||||
DUPILUMAB, |
||||
| 1853 | 26737866 |
US |
15 | 1 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1854 | 26737874 |
US |
58 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 1855 | 26737886 |
US |
21 | 2 |
Sleep disorder due to a general medical condition, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1856 | 26737887 |
US |
1 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1857 | 26737888 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1858 | 26737893 |
US |
29 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1859 | 26737927 |
US |
77 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1860 | 26737931 |
US |
49 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1861 | 26737947 |
US |
37 | 1 |
Eczema, Dermatitis atopic, Muscle tightness, Rash, Pruritus, Skin exfoliation, Gout, Myalgia, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, ALLOPURINOL, |
||||
| 1862 | 26737960 |
US |
96 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1863 | 26737965 |
GB |
25 | 2 |
Cryptosporidiosis infection, Dry skin, Inappropriate schedule of product administration, Stress, Lip injury, Dermatitis atopic, Pruritus, Erythema, Discomfort, Eye pruritus, Ocular hyperaemia, Therapeutic response shortened, Therapeutic response decreased, Skin irritation, Dry eye, Rash erythematous, Skin disorder, |
||||
DUPILUMAB, |
||||
| 1864 | 26738690 |
KR |
49 | 1 |
Therapy non-responder, Dermatitis atopic, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1865 | 26739026 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1866 | 26739059 |
US |
2 | |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1867 | 26739068 |
US |
66 | 2 |
Dermatitis atopic, Skin exfoliation, Eyelid rash, |
||||
DUPILUMAB, |
||||
| 1868 | 26739090 |
US |
1 | |
Dermatitis atopic, Product prescribing issue, |
||||
DUPILUMAB, |
||||
| 1869 | 26739104 |
US |
76 | 2 |
Pruritus, Rash, Dermatitis atopic, Rash erythematous, |
||||
DUPILUMAB, |
||||
| 1870 | 26739118 |
US |
4 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1871 | 26739129 |
US |
5 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1872 | 26739139 |
US |
18 | 1 |
Erythema, Pruritus, Skin burning sensation, Psoriasis, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1873 | 26739165 |
US |
16 | 2 |
Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1874 | 26739174 |
US |
36 | 2 |
Dermatitis atopic, Rash, |
||||
DUPILUMAB, |
||||
| 1875 | 26739180 |
US |
57 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1876 | 26739189 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1877 | 26739196 |
US |
25 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1878 | 26739313 |
US |
76 | |
Peripheral swelling, Rash, Quality of life decreased, Dermatitis atopic, Loss of personal independence in daily activities, Drug effect less than expected, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 1879 | 26739529 |
US |
1 | |
Dermatitis atopic, Inappropriate schedule of product administration, Pruritus, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 1880 | 26739535 |
US |
1 | |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 1881 | 26739537 |
US |
10 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 1882 | 26740199 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1883 | 26740200 |
US |
47 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1884 | 26740222 |
US |
23 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1885 | 26740482 |
US |
59 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1886 | 26740501 |
US |
63 | 2 |
Dermatitis atopic, Stress, |
||||
DUPILUMAB, |
||||
| 1887 | 26740727 |
US |
38 | 1 |
Eczema, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1888 | 26741036 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1889 | 26741039 |
US |
42 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, HYDROXYZINE, |
||||
| 1890 | 26741056 |
US |
69 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1891 | 26741147 |
US |
17 | 1 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1892 | 26741155 |
US |
24 | 1 |
Dermatitis atopic, Dry skin, Skin weeping, Pruritus, Skin haemorrhage, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, MAGNESIUM, VITAMIN C, |
||||
| 1893 | 26733323 |
US |
49 | |
Dermatitis atopic, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 1894 | 26733796 |
US |
2 | |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1895 | 26733814 |
US |
2 | |
Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1896 | 26733820 |
US |
20 | 2 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1897 | 26733824 |
US |
37 | 1 |
Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 1898 | 26733855 |
US |
1 | |
Dermatitis atopic, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, LEBRIKIZUMAB-LBKZ, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ORAL SEMAGLUTIDE, |
||||
| 1899 | 26733859 |
US |
83 | 2 |
Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 1900 | 26733860 |
US |
6 | 2 |
Eczema, Dermatitis atopic, Rash, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30